SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bonfida is known as the top infrastructure developer on Solana. This accolade has been earned from their contributions to the ecosystem by providing services and products that allow for the wider ecosystem to flourish.  Their contributions to the ecosystem include creating a new Serum Core engine, the Asset Agnostic Orderbook (AOB), simplifying the way users transact on Solana, and the first perpetual swap on Solana, Audaces, to name a few. As a result of these, their developers are highly respected within the Solana ecosystem.

Bonfida

Bonfida is seeing a significant surge in trading volume and community interest as market participants speculate on technical chart patterns and potential breakout momentum within the Solana ecosystem. While some investors are actively accumulating the asset, others remain cautious and are debating whether this activity represents a sustainable rally or a temporary trend.

Memecoin on Injective taken over by the community.

Nonja

Nonja is gaining significant traction as a top-tier meme coin on the Injective blockchain, with the community highlighting its superior liquidity-to-market-cap ratio and resilience throughout extended market downturns. Investors are actively rotating into the project, viewing it as a high-leverage opportunity to benefit from Injective's improving fundamentals and anticipated ecosystem growth.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

The KOLD and BOIL tickers are experiencing significant volatility as market participants debate whether natural gas remains insulated from Middle East geopolitical tensions or if major infrastructure disruptions will trigger a massive supply shock. The community is actively trading the wide price swings while debating the impact of upcoming storage reports, weather-driven demand fluctuations, and the potential for a larger breakout in the energy sector.

Tema ETF Trust - Tema Space Innovators ETF

NASA is trending as investors aggressively build positions to secure exposure to SpaceX ahead of its highly anticipated IPO. The community is focused on the ETF's strategic inclusion of SpaceX through special purpose vehicles, with many users debating whether it serves as a safer, long-term alternative to volatile individual space stocks.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax is facing significant selling pressure as investors react to a challenging earnings report that highlighted declining retail unit sales and increased loan loss provisions. The community is sharply divided, with some investors viewing the steep valuation drop as an oversold buying opportunity, while critics argue the company's business model is struggling under the weight of high inventory costs and broader automotive sector headwinds.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is capturing community attention through its expansion into real-world fitness products and persistent branding that resonates across multiple platforms. Investors are actively discussing the token's potential as a long-term play, citing its durable meme status and community-led growth as key catalysts for future performance.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is trending as investors focus on the company's robust oncology pipeline and the anticipated data readouts for its lead asset, darovasertib, in uveal melanoma. The community is actively discussing the stock's long-term valuation potential following recent pivotal trial results, while also debating the impact of ongoing institutional accumulation and the strategic implications of upcoming medical conference presentations.

LPKF Laser & Electronics SE engages in the provision of laser-based solutions for the technology industry. It operates through the following segments: Electronics, Development, Welding, and Solar. The Electronics segment refers to the production systems for cutting print stencils, circuit boards, thin glass, and the etching of plastic circuit carriers. The Development segment includes circuit board plotters and ProtoLasers, primarily for electronics developers. The Welding segment comprises systems for laser beam welding of plastic components. The Solar segment develops and produces laser scribers for the etching of thin-film solar cells and laser systems for the digital printing of functional pastes and inks. The company was founded by Jurgen Seebach, Klaus Barke, Klaus Sülter, and Bernd Hildebrandt in 1976 and is headquartered in Garbsen, Germany.

LPKF Laser & Electronics SE

Investors are increasingly bullish on LPKF due to the potential of its LIDE technology to revolutionize semiconductor manufacturing as the industry transitions to glass substrates for AI-driven hardware. The community remains focused on the companys long-term growth prospects, viewing it as a strategic, under-the-radar 'picks and shovels' play within the expanding photonics and advanced packaging sector.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro (PBR) is trending as investors weigh strong production milestones and favorable dividend prospects against geopolitical tensions in the Middle East and ongoing concerns regarding Brazilian government policy. Market participants are actively discussing the stock's valuation relative to its peers, the impact of fluctuating oil prices on future distributions, and the broader implications of regional energy supply dynamics.

SPX6900 is an advanced blockchain cryptography token coin capable of limitless possibilities and scientific utilization.

SPX6900

SPX6900 is drawing significant attention from investors who view it as a high-potential cult asset, with many in the community advocating for consistent dollar-cost averaging as a long-term play. Discussions are heavily focused on the coin's potential to mirror the rapid growth of historical meme-driven market successes, as followers remain resilient despite recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility PR Newswire JERUSALEM, May 20, 2026 JERUSALEM, May 20, 2026 /PRNewswire/ Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai...

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe Scinai Immunotherapeutics to Lead...

Best Penny Stocks To Add to Your Watchlist - April 24th

AEye, Elong Power, Bitfarms, Scinai Immunotherapeutics, and Keel Infrastructure are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of...

Chip Giants lead Breakout as Biotech Funding and Trading Frenzies re-emerge

The mega-cap semiconductors are breaking out on real earnings and AI demand, which is dominating the session, while liquidity is flowing into infrastructure and growth plays. $KBLB, $GOOG, $NVND, $INTC, $AMD, $POET, $CTNT, $SCNI

Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding

Biotech investors spent much of the past year pulling back from speculative microcap names as higher rates, tighter capital markets, and regulatory uncertainty pressured valuations across the sector. That trend has started to shift as targeted institutional money moves back into select names, particularly in immunology, inflammation therapeutics, and the contract development and manufacturing organization (CDMO) space, where pharmaceutical companies continue diversifying manufacturing capacity and supply chain exposure.Shares of Scinai Immunotherapeutics (NASDAQ: SCNI) are surging Friday ...

Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today

Scinai Immunotherapeutics shares are surging Friday after it announced fresh financing tied to a private placement and warrant exercise.read more...

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing PR Newswire JERUSALEM, April 24, 2026...

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities Scinai Completes Strategic Reorganization to Establish Dedicated CDMO...

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and...

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

SCNI
Scinai Immunotherapeutics Ltd.

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest SCNI News

SCNIScinai Immunotherapeutics Ltd.